Baxter International, Inc. (NYSE:BAX)
| CAPS Rating |
|
|---|---|
| Open | $56.52 |
| Previous Close | $56.80 |
| Daily Range | $56.21 - $56.84 |
| 52-Week Range | $47.55 - $62.50 |
| Market Cap | $32.30B |
| P/E Ratio | 15.60 |
| Dividend (Yield) | 1.34 (2.00%) |
| Volume | 2,585,917 |
| Average Daily Volume | 0 |
BAX
VS S&P 500 (SPY)
How do you think BAX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BAX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BAX News and Commentary
- All Good Things Must Come to an End – The Motley Fool
- Earnings Scorecard: Baxter - Analyst Blog – NASDAQ
- Becton Beats, Profit Drops - Analyst Blog – NASDAQ
- Earnings Preview: Becton, Dickinson - Analyst Blog – NASDAQ
- What Baxter International Does With Its Cash – The Motley Fool
- Golf Clap for Baxter International – The Motley Fool
- Baxter Beats Estimates - Analyst Blog – NASDAQ
- UPDATE: Baxter 4Q Profit Up 9.5% On Revenue Growth; Earnings Views Weak – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Baxter 4Q Profit Up 9.5% On Revenue Growth; Earnings Views Weak – SmartMoney
- Baxter International Passes This Key Test – The Motley Fool
- Earnings Preview: Baxter - Analyst Blog – NASDAQ
- Why the Street Should Love Baxter International's Earnings – The Motley Fool
- Integra's Prelim Results Disappoint - Analyst Blog – NASDAQ
- 5-Star Stocks Poised to Pop: Stryker – The Motley Fool
- Trendsetters to Watch in 2012 – The Motley Fool
- Applications Given Early Antitrust Clearance – SmartMoney
- Baxter Collaborates with Momenta - Analyst Blog – NASDAQ
- 2012 Newest Biotech Trend – The Motley Fool
- Momenta Pharmaceuticals in Spotlight as Interest in Biotech Copycats Rise – Minyanville
RSS Headlines
Fool UK
